1. Home
  2. AZZ vs IDYA Comparison

AZZ vs IDYA Comparison

Compare AZZ & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AZZ Inc.

AZZ

AZZ Inc.

HOLD

Current Price

$153.24

Market Cap

4.4B

Sector

Industrials

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$36.54

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZZ
IDYA
Founded
1956
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.6B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
AZZ
IDYA
Price
$153.24
$36.54
Analyst Decision
Buy
Strong Buy
Analyst Count
5
16
Target Price
$141.80
$52.86
AVG Volume (30 Days)
216.2K
663.4K
Earning Date
04-22-2026
05-06-2026
Dividend Yield
0.58%
N/A
EPS Growth
486.59
61.90
EPS
1.72
N/A
Revenue
$1,061,817,000.00
$218,710,000.00
Revenue This Year
$7.03
N/A
Revenue Next Year
$4.25
$201.05
P/E Ratio
$87.99
N/A
Revenue Growth
14.53
3024.43
52 Week Low
$92.98
$23.23
52 Week High
$162.20
$40.58

Technical Indicators

Market Signals
Indicator
AZZ
IDYA
Relative Strength Index (RSI) 53.68 53.90
Support Level $132.06 $34.29
Resistance Level $152.83 $37.82
Average True Range (ATR) 3.87 1.13
MACD 0.19 -0.06
Stochastic Oscillator 67.64 66.45

Price Performance

Historical Comparison
AZZ
IDYA

About AZZ AZZ Inc.

AZZ Inc is a provider of galvanizing and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of AZZ Metal Coatings, AZZ Precoat Metals, and AZZ Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company operates in the United States and Canada.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: